설하면역치료

키워드

참고문헌 (63)

1. Scadding GK, "Low dose sublingual therapy in patients with allergic rhinitis due to house dust mite", Clin Allergy, 16(5), pp.483~491 (1986)
2. "Immunotherapy", Allergy, 48(14 Suppl), pp.7~35 (1993), The European Academy of Allergy and Clinical Immunology
3. Bousquet J, "Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper", J Allergy Clin Immunol, 102(4 Pt 1), pp.558~562 (1998)
4. Bousquet J, "Allergic rhinitis and its impact on asthma", J Allergy Clin Immunol, 108(5Suppl), pp.S147~S334 (2001), Aria Workshop Group World Health Organization
5. Bousquet J, "Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)", Allergy, 63(Suppl 86), pp.8~160 (2008)
6. Passalacqua G, "Global Allergy and Asthma European Network. Allergic rhinitis and its impact on asthma update: allergen immunotherapy", J Allergy Clin Immunol, 119(4), pp.881~891 (2007)
7. Zemann B, "Oral administration of specific antigens to allergy-prone infant dogs induces IL-10 and TGF-beta expression and prevents allergy in adult life", J Allergy Clin Immunol, 111(5), pp.1069~1075 (2003)
8. Allam JP, "Characterization of dendritic cells from human oral mucosa: a new Langerhans’ cell type with high constitutive FcepsilonRI expression", J Allergy Clin Immunol, 112(1), pp.141~148 (2003)
9. Allam JP, "Toll-like receptor 4 ligation enforces tolerogenic properties of oral mucosal Langerhans cells", J Allergy Clin Immunol, 121(2), pp.368~374 (2008)
10. Van Wilsem EJ, "Dendritic cells of the oral mucosa and the induction of oral tolerance. A local affair", Immunology, 83(1), pp.128~132
11. Didier A, "Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis", J Allergy Clin Immunol, 120(6), pp.1338~1345 (2007)
12. Dahl R, "Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years", J Allergy Clin Immunol, 121, pp.512~8.e2 (2008)
13. Bahceciler NN, "Impact of sublingual immunotherapy on specific antibody levels in asthmatic children allergic to house dust mites", Int Arch Allergy Immunol, 136(3), pp.287~294 (2005)
14. Passalacqua G, "Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in miteinduced rhinoconjunctivitis", Lancet, 351(9103), pp.629~632 (1998)
15. Ippoliti F, "Immunomodulation during sublingual therapy in allergic children", Pediatr Allergy Immunol, 14(3), pp.216~221 (2003)
16. Bohle B, "Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation", J Allergy Clin Immunol, 120(3), pp.707~713 (2007)
17. Fanta C, "Systemic immunological changes induced by administration of grass pollen allergens via the oral mucosa during sublingual immunotherapy", Int Arch Allergy Immunol, 120(3), pp.218~224 (1999)
18. Rolinck-Werninghaus C, "Lack of detectable alterations in immune responses during sublingual immunotherapy in children with seasonal allergic rhinoconjunctivitis to grass pollen", Int Arch Allergy Immunol, 136(2), pp.134~141 (2005)
19. Fenoglio D, "Sublingual specific immunotherapy reduces PBMC proliferations", Eur Ann Allergy Clin Immunol, 37(4), pp.147~151 (2005)
20. Ciprandi G, "Sublingual immunotherapy induces spirometric improvement associated with IL-10 production: preliminary reports", Int Immunopharmacol, 6(8), pp.1370~1373 (2006)
21. Dahl R, "Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis", Allergy, 61(2), pp.185~190 (2006)
22. Röder E, "Sublingual immunotherapy with grass pollen is not effective in symptomatic youngsters in primary care", J Allergy Clin Immunol, 119(4), pp.892~898 (2007)
23. Bousquet J, "Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to housedust mites: a double-blind, placebo-controlled study", Allergy, 54(3), pp.249~260 (1999)
24. Pajno GB, "Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, placebo-controlled study", Allergy, 55(9), pp.842~849 (2000)
25. Wilson DR, "Sublingual immunotherapy for allergic rhinitis", Cochrane Database Syst Rev, (2) (2003)
26. Calamita Z, "Efficacy of sublingual immunotherapy in asthma: systematic review of randomized-clinical trials using the Cochrane Collaboration method", Allergy, 61(10), pp.1162~1172 (2006)
27. Penagos M, "Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials", Ann Allergy Asthma Immunol, 97(2), pp.141~ (2006)
28. Quirino T, "Sublingual versus injective immunotherapy in grass pollen allergic patients: a double blind (double dummy) study", Clin Exp Allergy, 26(11), pp.1253~1261 (1996)
29. Khinchi MS, "Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study", Allergy, 59(1), pp.45~53 (2004)
30. Piazza I, "Humoral response to subcutaneous, oral, and nasal immunotherapy for allergic rhinitis due to Dermatophagoides pteronyssinus", Ann Allergy, 71(5), pp.461~469 (1993)
31. Mungan D, "Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma--a placebo controlled study", Ann Allergy Asthma Immunol, 82(5), pp.485~490 (1999)
32. Mauro M, "Comparison of efficacy, safety and immunologic effects of subcutaneous and sublingual immunotherapy in birch pollinosis: a randomized study", Eur Ann Allergy Clin Immunol, 39(4), pp.119~122 (2007)
33. Enrique E, "Sublingual immunotherapy for hazelnut food allergy: a follow-up study", Ann Allergy Asthma Immunol, 100(3), pp.283~284 (2008)
34. Pajno GB, "Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study", J Allergy Clin Immunol, 120(1), pp.164~170 (2007)
35. Stewart GE 2nd, "Systemic reactions from allergen immunotherapy", J Allergy Clin Immunol, 90(4 Pt 1), pp.567~578 (1992)
36. Blazowski L, "Anaphylactic shock because of sublingual immunotherapy overdose during third year of maintenance dose", Allergy, 63(3), pp.374~ (2008)
37. Dunsky EH, "Anaphylaxis to sublingual immunotherapy", Allergy, 61(10), pp.1235~ (2006)
38. Eifan AO, "Anaphylaxis to multiple pollen allergen sublingual immunotherapy", Allergy, 62(5), pp.567~568 (2007)
39. Antico A, "Anaphylaxis by latex sublingual immunotherapy", Allergy, 61(10), pp.1236~1237 (2006)
40. de Groot H, "Anaphylactic reaction after the first dose of sublingual immunotherapy with grass pollen tablet", Allergy, 64(6), pp.963~964 (2009)
41. Agostinis F, "The safety of sublingual immunotherapy with one or multiple pollen allergens in children", Allergy, 63(12), pp.1637~1639 (2008)
42. Lombardi C, "Passalacqua G. The safety of sublingual immunotherapy with one or more allergens in adults", Allergy, 63(3), pp.375~376 (2008)
43. Guerra S, "Rhinitis is an independent risk factor for developing cough apart from colds among adults", Allergy, 60(3), pp.343~349 (2005)
44. Lombardi C, "The natural history of respiratory allergy: a follow-up study of 99 patients up to 10 years", Respir Med, 95(1), pp.9~12 (2001)
45. Cruz AA, "Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA(2)LEN", Allergy, 62(Suppl 84), pp.1~41 (2007)
46. Marogna M, "The type of sensitizing allergen can affect the evolution of respiratory allergy", Allergy, 61(10), pp.1209~1215 (2006)
47. Jacobsen L, "Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study", Allergy, 62(8), pp.943~948 (2007)
48. Novembre E, "Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis", J Allergy Clin Immunol, 114(4), pp.851~857 (2004)
49. Marogna M, "Preventive effects of sublingual immunotherapy in childhood: an open randomized controlled study", Ann Allergy Asthma Immunol, 101(2), pp.206~211 (2008)
50. Di Rienzo V, "Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study", Clin Exp Allergy, 33(2), pp.206~210 (2003)
51. Marogna M, "Long-lasting effects of sublingual immunotherapy for house dust mites in allergic rhinitis with bronchial hyperreactivity: a long-term (13-year) retrospective study in real life", Int Arch Allergy Immunol, 142(1), pp.70~78 (2007)
52. Valovirta E, "Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children", Allergy, 61(10), pp.1177~1183 (2006)
53. Bahçeciler NN, "Efficacy of sublingual immunotherapy in childrenwith asthma and rhinitis: a double-blind, placebo-controlled study", Pediatr Pulmonol, 32(1), pp.49~55 (2001)
54. Hirsch T, "Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite extract (D.pt.) in children", Pediatr Allergy Immunol, 8(1), pp.21~27 (1997)
55. Pajno GB, "Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study", J Allergy Clin Immunol, 120(1), pp.164~170 (2007)
56. de Boissieu D, "Sublingual immunotherapy for cow’s milk protein allergy: a preliminary report", Allergy, 61(10), pp.1238~1239 (2006)
57. Bousquet J, "Consensus statements, evidencebased medicine and guidelines in allergic diseases", Allergy, 63(1), pp.1~4 (2008)
58. Sackett DL, "The need for evidence-based medicine", J R Soc Med, 88(11), pp.620~624 (1995)
59. Bousquet J, "Allergic rhinitis and its impact on asthma", J Allergy Clin Immunol, 108(5 Suppl), pp.S147~S334 (2001), Aria Workshop Group World Health Organization
60. Bousquet J, "Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)", Allergy, 63(Suppl 86), pp.8~160 (2008)
61. Bousquet J, "Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology", Ann Allergy Asthma Immunol, 81(5 Pt 1), pp.401~405 (1998)
62. Bousquet J, "Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper", J Allergy Clin Immunol, 102(4 Pt 1), pp.558~562 (1998)
63. Cox LS, "Sublingual immunotherapy: a comprehensive review", J Allergy Clin Immunol, 117(5), pp.1021~1035 (2006)

관련 논문AI추천